에서 실시간으로 운영 중이에요! 자세히 알아보기

Rockwell Medical

RMTI

시가총액 US$2995만

7.43 USD

-0.55

6.89%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

1일

-6.89%

5일

-5.47%

1개월

-4.74%

3개월

29.67%

6개월

-18.89%

연초 이후

-13.9%

1년

-37.56%

5년

-88.04%

10년

-98.82%

소개: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

직원 수: 157

건강관리 의약품 제조업체 - 전문의약품 및 제네릭

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 0%

중립 77.8%

부정적 22.2%

Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026.

Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026

Rockwell Medical to Exhibit at ASN Kidney Week 2026

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.

Rockwell Medical to Exhibit at ASN Kidney Week 2026

Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to #16 (2026).

Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List

Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

Rockwell Medical Announces Second Quarter 2026 Results

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.

Rockwell Medical Announces Second Quarter 2026 Results

Zacks Investment Research

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical Advances Quality and Regulatory Leadership

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Company.

Rockwell Medical Advances Quality and Regulatory Leadership

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.

Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.